Source: International Congress 2019 – Pathogenesis and prognosis of interstitial lung disease of known origin
Disease area: -



Rating:

Share or cite this content

Citations should be made in the following way:
K. Guenther (Giessen, Germany), W. Seeger (Giessen, Germany), A. Guenther (Giessen, Germany), M. Korfei (Giessen, Germany). Cellular consequences of uncharacterized surfactant protein-A2 (SFTPA2)-gene mutations associated with familial IPF and lung cancer. 1608

Member's Comments

No comment yet.

Related content which might interest you: Functional assessment and phenotypic heterogeneity of SFTPA1 and SFTPA2 mutations in interstitial lung diseases and lung cancer Source: Eur Respir J, 56 (6) 2002806; 10.1183/13993003.02806-2020 Year: 2020 Familial interstitial lung disease and ABCA3 gene Gly964Asp mutation Source: Annual Congress 2010 - Pathogenesis of diffuse parenchymal lung disease Year: 2010 Distinct forms of BARD1 expressed in lung fibrosis and lung cancer Source: Eur Respir J 2006; 28: Suppl. 50, 325s Year: 2006 SFTPA mutations in interstitial lung disease (ILD) and lung cancer Source: International Congress 2017 – Rare diseases Year: 2017 Role of ABCA3 in paediatric interstitial lung disease associated with surfactant protein C gene mutations Source: Annual Congress 2009 - Genetics of lung diseases Year: 2009 Mutations in SFTPC, SFTPA2 and TERT explain 60% of familial pulmonary fibrosis and correlate to specific disease phenotypes Source: Annual Congress 2011 - Genetic and molecular background in pulmonary fibrosis Year: 2011 The 15q24/25 susceptibility variant for lung cancer and COPD is associated with emphysema Source: Annual Congress 2010 - Lung cancer, idiopathic pulmonary fibrosis and sarcoidosis: the genetic approach Year: 2010 Classification of different ABCA3 mutations causing interstitial lung disease Source: International Congress 2015 – New insights into IIPs Year: 2015 A novel non-BRICHOS surfactant protein C mutation causing infantile interstitial lung disease is associated with reduced mature SP-C level Source: International Congress 2018 – Orphan diseases in children Year: 2018 Polymorphisms associated with lung cancer are closely related to COPD Source: Eur Respir J 2007; 30: Suppl. 51, 136s Year: 2007 Functional assessment of newly identified SFTPA1 and SFTPA2 mutations in patients with idiopathic interstitial pneumonia (IIP) and lung cancer Source: International Congress 2018 – New insights in rare diffuse parenchymal lung diseases (DPLDs) in adults and children Year: 2018 TERT expression in lung cancer associated with IPF: a case-control study Source: Virtual Congress 2021 – Translational and other aspects of idiopathic interstitial pneumonia Year: 2021 Association of polymorphism of the human nm23-H1 gene (NME1) with susceptibility to and severity of non-small cell lung cancer Source: Annual Congress 2007 - Diagnosis and prognosis in thoracic oncology Year: 2007 Subtypes of lung adenocarcinomas associated with IPF Source: International Congress 2019 – Comorbidities of idiopathic pulmonary fibrosis Year: 2019 Germline SFTPA1 mutation in familial idiopathic interstitial pneumonia and lung cancer Source: International Congress 2016 – IPF pathogenesis Year: 2016 Polymorphisms in telomere maintenance genes and risk of lung cancer Source: Annual Congress 2009 - Pathogenesis of lung cancer Year: 2009 Circulating MUC1 is associated with thrombophilic state in lung diseases Source: Eur Respir J 2004; 24: Suppl. 48, 505s Year: 2004 Polymorphism of the MUC1 mucin gene is associated with susceptibility to lung adenocarcinoma and poor prognosis Source: Annual Congress 2005 - Prognostic factors in lung cancer Year: 2005 Immune-checkpoint inhibitors associated with interstitial lung disease in cancer patients Source: Eur Respir J, 50 (2) 1700050; 10.1183/13993003.00050-2017 Year: 2017 Combined effect of p53 and XRCC1 gene polymorphisms on age-associated lung cancer risk Source: Annual Congress 2008 - Discovery of novel targets in lung disease by means of functional genomics Year: 2008